cabozantinib,avelumab
exelixis,pfizer
['urothelial', '2001', 'main-cav', 'cabozantinib', 'avelumab']
#cctg @ #asco22 #asco2022 blc.5/alliance a032001
main-cav: phase iii randomized trial of maintenance cabozantinib and avelumab versus avelumab after first-line platinum-based chemotherapy in patients with metastatic urothelial cancer abstract link: 
The Canadian Cancer Trials Group is a cancer clinical trials research cooperative that runs phase I-III trials to test anti-cancer and supportive therapies.